CURE Pharmaceutical Adds New VP of Strategy and Business Development

CURE Pharmaceutical Adds New VP of Strategy and Business Development January 25, 2018 LOS ANGELES–(BUSINESS WIRE)– CURE Pharmaceutical (OTCQB: CURR) (“CURE”), an innovative drug delivery and development company, today named Dr. Vered Gigi, Vice President of Strategy and Business Development. Dr. Gigi will oversee CURE’s strategy to deliver sustained growth and diversified revenue. “We are…

CURE Pharmaceutical Launches New Brand Focused on Patient Needs in Medication Delivery

OXNARD, Calif., Jan. 04, 2018 (GLOBE NEWSWIRE) — CURE Pharmaceutical (OTCQB:CURR), (“CURE”), an innovative drug delivery and development company, announced the launch of their new brand initiative, inspired by the company’s mission to support patient needs for better delivery of medication. “Our new branding offers an opportunity to elevate awareness around the challenges patients experience…

Wealth Receives Positive Results from Tenova Advanced Technologies Process Study for the Laguna Verde Project in Chile

Test Work Demonstrates that Tenova Advanced Technologies’ Process Technology can be Successfully Applied to the Laguna Verde Surface Brines November 16, 2017 08:00 ET | Source: Wealth Minerals Ltd. Wealth Minerals Ltd. VANCOUVER, British Columbia, Nov. 16, 2017 (GLOBE NEWSWIRE) — Wealth Minerals Ltd. (the “Company” or “Wealth”) – (TSX-V:WML) (OTCQB:WMLLF) (SSE:WMLCL) (Frankfurt:EJZN) announces that…

Energy Fuels Enters into Agreement to Acquire and Extinguish Royalties on its Nichols Ranch Property as well as Acquire and Hold Royalties on Nearby Operating and Permitted ISR Uranium Projects Owned by Cameco

November 13, 2017 LAKEWOOD, CO , Nov. 13, 2017 /CNW/ – Energy Fuels Inc. (NYSE American: UUUU; TSX: EFR) (“Energy Fuels” or the “Company”), a leading producer of uranium in the United States , is pleased to announce that it has entered into an agreement (the “Agreement”) to acquire all of the issued and outstanding…